01:31 PM EDT, 08/25/2025 (MT Newswires) -- AbbVie ( ABBV ) will acquire Gilgamesh Pharmaceuticals' investigational depression drug for up to $1.2 billion, expanding its psychiatry pipeline, the companies said Monday. The acquisition price for Gilgamesh' lead asset, bretisilocin, includes an upfront payment and milestones-based consideration. The transaction is subject to closing conditions. A phase 2a study of bretisilocin targeting...

(Reuters) -President Donald Trump told reporters on Monday that China has to give the United States magnets or we have to charge them 200% tariff or something amid a trade dispute between the two nations. China is increasingly sensitive about rare earths and its control over supply, adding several rare earth items and magnets to its export restriction list in...

01:40 PM EDT, 08/25/2025 (MT Newswires) -- ODP (ODP) reported Monday a hospitality purchasing contract with Omnia Partners, a group purchasing organization, through its ODP Business Solutions division. The contract allows ODP Business to provide members hospitality-focused products and services, such as linens, terry cloth towels, bathroom amenities, the company said. ODP shares were almost 4% lower in recent trading....

* Order had sparked security fears as rivalry with China intensifies * Decision removes potential flashpoint for new Chancellor Merz * Ming Yang says no longer involved in project * Merz set to make inaugural trip to China later this year By Riham Alkousaa and Sarah Marsh BERLIN, Aug 25 (Reuters) - A German company may scrap a deal with...